(19)
(11) EP 1 644 522 A2

(12)

(88) Date of publication A3:
14.07.2005

(43) Date of publication:
12.04.2006 Bulletin 2006/15

(21) Application number: 04740533.7

(22) Date of filing: 01.07.2004
(51) International Patent Classification (IPC): 
C12Q 1/68(1980.01)
(86) International application number:
PCT/EP2004/007167
(87) International publication number:
WO 2005/005661 (20.01.2005 Gazette 2005/03)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 02.07.2003 US 484465 P

(71) Applicants:
  • Novartis AG
    4056 Basel (CH)

    BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL 
  • Novartis Pharma GmbH
    1230 Wien (AT)

    AT 

(72) Inventor:
  • LAVEDAN, Christian, Nicolas
    Potomac, MD 20854 (US)

(74) Representative: von Sprecher, Georg et al
Novartis AG Corporate Intellectual Property
4002 Basel
4002 Basel (CH)

   


(54) GENES REGULATED IN OVARIAN CANCER AS PROGNOSTIC AND THERAPEUTIC TARGETS